Original language | English |
---|---|
Pages (from-to) | 623-624 |
Number of pages | 2 |
Journal | JAMA Oncology |
Volume | 4 |
Issue number | 5 |
DOIs |
|
State | Published - May 2018 |
Externally published | Yes |
The US food and drug administration’s approval of adjuvant sunitinib for renal cell cancer: A case of regulatory capture?
Bishal Gyawali*, Daniel A. Goldstein
*Corresponding author for this work
Research output: Contribution to journal › Comment/debate